Search results
2023 Highlights in Canadian Life Sciences IP and Regulatory Law | JD Supra
JD Supra· 6 days agoThe FC found the third patent claiming an aqueous formulation of adalimumab valid, with infringement conceded, but declined to grant a permanent injunction in view of the ...
Is Your Intellectual Property Safe With Indian CROs And CDMOs?
BioresearchOnline· 3 days agoPlease note: This is not a legal document, although I have included input from attorneys based in...
Mechanic Prince Of Tides
Hackaday· 21 hours agoLord Kelvin’s name comes up anytime you start looking at the history of science and technology. In addition to working on transatlantic cables and...
Q4 2024 Roivant Sciences Ltd Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 6 days agoBut notably, because the way those studies are designed, we retain full optionality for registration of batoclimab if the data is supportive. And then, finally, I think an underappreciated fact ...
Tempo Therapeutics Announces Appointment of Eric I. Richman to Board of Directors
Morningstar· 3 hours agoTempo Therapeutics, Inc. ("Tempo"), a leading innovator in tissue engineering and regenerative medicine, today announced the addition of Eric I. Richman, MBA to its board of directors. "After ...
Unpacking AI-Assisted Drug Discovery Patents | JD Supra
JD Supra· 6 days agoPatenting drugs discovered with AI assistance requires “significant” human input. There are sever always to satisfy that requirement—including some that may not be obvious ...
LSU professor working on cancer treatment treating tumors with strep throat bacteria
WVLA Baton Rouge via Yahoo News· 2 days agoLSU Biological Sciences Professor Roger Laine is working on a treatment that involves CM101,...
A year ago, Takeda pledged to create local jobs in exchange for $1.8 million in tax breaks. Now,...
The Boston Globe· 6 days agoMichael Nedelcovych, an analyst at TD Cowen in Boston, said Takeda’s planned layoffs “weren’t hugely...
Road to InfoComm 2024: Glensound, Cobalt Make InfoComm Debut
AV Network via Yahoo News· 18 hours agoScalable was founded in 2004, making the company the original inventor and initial patent holder of...
Scientists Race To Perfect New Oral COVID-19 Treatment Poised To Replace Paxlovid
SciTechDaily· 3 days agoRutgers researchers are advancing a potential new COVID-19 treatment, Jun12682, which is effective in animal studies and compatible with other medications, unlike the current leading treatment ...
